Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Cheung

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphomaJia Ruan, Peter Martin, Richard R Furman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
International Journal of Behavioral Medicine|September 4, 2024
Feasibility Test of Personalized (N-of-1) Trials for Increasing Middle-Aged and Older Adults' Physical ActivityCiarán P Friel, Ashley M Goodwin, Patrick L Robles, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Characterizing the dual burden of stigma in people with multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in South Africa: A mixed methods, prospective cohort studyKarl Reis, Xuan Lu, Boitumelo Seepamore, et al.
Molecular Biosystems|October 11, 2016
'Light up' protein-protein interaction through bioorthogonal incorporation of a turn-on fluorescent probe into β-lactamaseRui Hu, Hong-Kin Yap, Yik-Hong Fung, et al.
The Journal of Clinical Investigation|June 7, 2005
Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanomaHoward L Kaufman, Gail Deraffele, Josephine Mitcham, et al.
Annual Review of Public Health|April 7, 2017
An Overview of Research and Evaluation Designs for Dissemination and ImplementationC Hendricks Brown, Geoffrey Curran, Lawrence A Palinkas, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
The Journal of Infectious Diseases|March 9, 2026
Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancyLauren B Reoma, Tory P Johnson, Ken Cheung, et al.
Neurology. Genetics|June 25, 2024
Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related DystrophyA Reghan Foley, Pomi Yun, Meganne E Leach, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphomaJia Ruan, Peter Martin, Richard R Furman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
International Journal of Behavioral Medicine|September 4, 2024
Feasibility Test of Personalized (N-of-1) Trials for Increasing Middle-Aged and Older Adults' Physical ActivityCiarán P Friel, Ashley M Goodwin, Patrick L Robles, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Characterizing the dual burden of stigma in people with multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in South Africa: A mixed methods, prospective cohort studyKarl Reis, Xuan Lu, Boitumelo Seepamore, et al.
Molecular Biosystems|October 11, 2016
'Light up' protein-protein interaction through bioorthogonal incorporation of a turn-on fluorescent probe into β-lactamaseRui Hu, Hong-Kin Yap, Yik-Hong Fung, et al.
The Journal of Clinical Investigation|June 7, 2005
Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanomaHoward L Kaufman, Gail Deraffele, Josephine Mitcham, et al.
Annual Review of Public Health|April 7, 2017
An Overview of Research and Evaluation Designs for Dissemination and ImplementationC Hendricks Brown, Geoffrey Curran, Lawrence A Palinkas, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
The Journal of Infectious Diseases|March 9, 2026
Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancyLauren B Reoma, Tory P Johnson, Ken Cheung, et al.
Neurology. Genetics|June 25, 2024
Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related DystrophyA Reghan Foley, Pomi Yun, Meganne E Leach, et al.
Pageof 9